CDC20064
NTP
2000 18.6%
46.5%
27.8%
20007.6%
17.1%
10.7%
617.6% 17.3% 16.6% 2.8% 1.5% 1.3%)
8
% 1996 35.0 66.0 40.52001 29.8 60.8 35.5 35.7 65.3 44.8 42.1 55.8 43.3 17.6 50.0 24.5 17.5 44.5 23.3 14.8 59.3 21.9 13.0 38.1 15.5
8
8
% 1996 14.6 43.5 19.72001 9.6 42.6 15.3 9.8 51.0 21.2 11.4 29.1 13.1 3.8 23.2 7.9 3.8 26.9 8.8 6.5 45.0 12.6 3.5 22.2 5.3
(Mycobaterium)1007(M.tuberculosis).7
Nontuberculosis Mycobacteria,NTM
Rubyun
-
37
37PH6.8~7.210~1810~30
(1)
(2) (3).
()1~24%NaOH)1min15~20min
0.5~1ml3000r/min30min[2~42%NaOH)15min] 4~5h,10ml,3000r/min30 min,[4%H2SO4,15min].
()
() 4%H2SO41325min)0.1mlL-J225min, .
()
,24h,L-J; 3000r/min30 min,L-J.,[4%NaOH),10~15min]L-J
,;,3000r/min10 min;[2~44%H2SO4],15~20 min)L-J. ,, 4%NaOH),15 min.
1~24%NaOH1~2min15min0.1ml237
3,7,
,8
xg++/12601.87.10.2530004.511.20.4038009.611.60.83
1.37118
2.2%~5%
(1):,,.(2)1/4(3)21/2(4)33/4(5)4(6):1/4
20.
10~100/
2~87~8
,
Bectec -TB64014C14CCO2CO24~25
Bectec-tb9607H9O7~4260
Bect/alert 3DCO2 CO2 CO210
3~6
G. Meissner () 1964,30 G. Canetti J.Grossete1963 ,WHO .D.A.Mitchison,,.
,(WHO) ,30 ,WHO ,
2,4 96 %,,HSR E
,: (1) 10-3mg,,,,2 10-4mg 10-6mg,,
(2) 1 %,20 ,1 %,2 ,,3
(KH2PO4)
1.2.(INH)(RFP)(TB1)(TH1321)(SC).SM-SO4)EMB-Cl)(KM-SO4)(CPM-SO4)(VM-SO4)(PAS-Na)
3.
=/1000mg % g/ml % ml
4 5.5~10ml,-20 3 RFPTB1TH1321
100ml1ml7ml85 50min.37 24h4 1
1 12 20.Tween-80MacFaarland No.1mg/ml
2.122mg/ml0.01 mg/ml0.1 mg/ml(a):22100222mg/ml2 ml0.01 mg/ml10010-4 mg/ml220.7mm,3mm0.01ml
2. (b)100.5ml1mg/ml4.50.1mg/ml.1010-2 mg/ml10-4 mg/ml
3.:221(0.01ml) 10-2 mg/ml10-4 mg/ml10-4 mg 10-6 mg4.:37 4
1..(1)50: (2)50~100: 1+(3)100~200: 2+(4)(200~500): 3+(5)(500): 4+
2.:=/*100%1%
1.(10-4 mg/ml)202.(H37RV)10-3 mg10.1ml 1%(BaCl2)9.9 ml 1%(H2SO4)
2~3mg/ml37 4
INHEMB 10-4+++++3 10-62690%34.60.1Rs
1234H37RV
12345
4
198012%89.6%8.0%4.3%
28 28 TNM
PNB-2-TCH
PNBTCH28 + NTM + + + + + +
3~4
7H9
L-JL-J
-45
Gen ProbeGEN-PROBE HPARNADNARNADNAGEN-PROBE LEADER
Gen ProbeGen ProbeGen ProbeMTDrRNA
Gen Probe18MTD2.53.5rRNAMTD